Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 10/2003

01-10-2003 | Symposium Series

Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay

Authors: Malcolm S. Mitchell, W. Martin Kast

Published in: Cancer Immunology, Immunotherapy | Issue 10/2003

Login to get access

Excerpt

The 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay was held under the auspices of the Albert B. Sabin Vaccine Institute on 5–8 March 2003. A select group of 36 scientists representing academia, biotechnology, and the pharmaceutical industry discussed the latest developments in basic science and clinical trials of cancer vaccines. This field has received increasing attention as preclinical developments and clinical applications have begun to demonstrate the usefulness of this promising approach to cancer treatment. Besides their formal presentations and discussions, the participants held informal discussions among themselves at recreational activities. The unique venue, a tropical island in the Bahamas, fostered close interactions among the participants and promoted the purposes of the meeting: development of therapeutic and preventive cancer vaccines. During the meeting the following papers were presented. …
Metadata
Title
Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay
Authors
Malcolm S. Mitchell
W. Martin Kast
Publication date
01-10-2003
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 10/2003
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-003-0438-z

Other articles of this Issue 10/2003

Cancer Immunology, Immunotherapy 10/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine